Providing Solutions for Your Clinical Trial Needs
At ClinTrial Solutions, we simplify the complexities of clinical trials by providing end-to-end clinical trial services for Sites, Sponsors, and Biotech Companies. We aim to streamline the clinical trial process, enabling our partners to eliminate the administrative burden, data quality, and regulatory pressure.
With expertise across phases I-IV and all therapeutic areas, we offer solutions tailored to each stakeholder's unique needs. Our services are designed to accelerate timelines while maintaining the highest standards of quality and compliance with global regulations.
Our Services
Site Consultancy: Expert guidance in Site level Consultancy - HREC and RGO submissions, budgeting, regulatory compliance, patient recruitment, and management
Extensive Network: Expert in feasibility, site identification, patient population, and regulatory bodies - Handpicking the correct stakeholders that can drive results.
Biotech and Sponsor Consultancy:Expert guidance in phase 1 trials - Specialist support in bridging the gap between lab to bedside. Strong focus on start-up and clinical trial monitoring.
Clinical Trials Operations: Streamlining clinical trial processes to reduce timelines and enhance data quality- Fast-tracking approval times.
Our Experience
Why Us?
Accelerate Timelines:
Outsourcing allows you to tap into the expertise of professionals who specialise in managing the intricacies of clinical operations and regulatory requirements - Allowing early patient access to novel treatments.
Cost Effective:
Much cheaper than hiring a CRO - With experience in feasibility to site close out, we have all the necessary expertise for clinical trials.
Risk Mitigation:
Mitigate the risk factors such as staff resignation and regulatory compliance - This will undoubtedly avoid delays in patient recruitment, data collection and regulatory approvals.
Diverse Experience:
Our team has a plethora of experience working with multiple different sites, sponsors, and biotech companies - With experience in activating phase 1-IV trials across a range of therapeutic areas.